Kush Dalal
Vancouver General Hospital(CA)AbCellera (Canada)(CA)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Estrogen and related hormone effects, Bacterial Genetics and Biotechnology, RNA and protein synthesis mechanisms, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants(2022)456 cited
- → Structure-Activity Analysis of Niclosamide Reveals Potential Role for Cytoplasmic pH in Control of Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling(2012)160 cited
- → Nanodiscs unravel the interaction between the SecYEG channel and its cytosolic partner SecA(2007)148 cited
- → Selectively Targeting the DNA-binding Domain of the Androgen Receptor as a Prospective Therapy for Prostate Cancer(2014)131 cited
- → Discovery of Small-Molecule Inhibitors Selectively Targeting the DNA-Binding Domain of the Human Androgen Receptor(2014)118 cited
- → Best Practices of Computer-Aided Drug Discovery: Lessons Learned from the Development of a Preclinical Candidate for Prostate Cancer with a New Mechanism of Action(2017)113 cited
- → Moving Towards Precision Urologic Oncology: Targeting Enzalutamide-resistant Prostate Cancer and Mutated Forms of the Androgen Receptor Using the Novel Inhibitor Darolutamide (ODM-201)(2017)106 cited
- → Targeting Alternative Sites on the Androgen Receptor to Treat Castration-Resistant Prostate Cancer(2013)67 cited
- → Androgen receptor-binding sites are highly mutated in prostate cancer(2020)62 cited
- → RPA nucleic acid-binding properties of IFI16-HIN200(2008)53 cited